Transjugular intrahepatic portosystemic shunt prior to renal transplantation in a child with autosomal-recessive polycystic kidney disease and portal hypertension: A case report

N Benador; P Grimm; J Lavine; P Rosenthal; V Reznik; J Lemire

doi:10.1034/j.1399-3046.2001.00061.x

Transjugular intrahepatic portosystemic shunt prior to renal transplantation in a child with autosomal-recessive polycystic kidney disease and portal hypertension: A case report

Pediatr Transplant. 2001 Jun;5(3):210-4. doi: 10.1034/j.1399-3046.2001.00061.x.

Authors

N Benador¹, P Grimm, J Lavine, P Rosenthal, V Reznik, J Lemire

Affiliation

¹ Divisions of Pediatric Nephrology and Gastroenterology, Department of Pediatrics, UCSD School of Medicine, La Jolla, CA 92093-0831, USA. [email protected]

PMID: 11422825
DOI: 10.1034/j.1399-3046.2001.00061.x

Abstract

Autosomal-recessive polycystic kidney disease (ARPKD) can cause renal failure and portal hypertension in children. Portal hypertension may complicate the course of renal transplantation (Tx). We report the successful outcome of a patient with end-stage renal disease (ESRD) and portal hypertension treated with transjugular intrahepatic portosystemic shunt (TIPS), a minimally invasive endovascular technique of portosystemic shunt, prior to renal Tx.

Publication types

Case Reports

MeSH terms

Child
Female
Graft Rejection / drug therapy
Graft Rejection / prevention & control
Humans
Hypertension, Portal / complications*
Hypertension, Portal / genetics
Hypertension, Portal / surgery*
Immunosuppression Therapy
Immunosuppressive Agents / therapeutic use
Kidney Failure, Chronic / etiology
Kidney Failure, Chronic / genetics
Kidney Failure, Chronic / surgery
Kidney Transplantation*
Polycystic Kidney, Autosomal Recessive / complications*
Polycystic Kidney, Autosomal Recessive / genetics
Polycystic Kidney, Autosomal Recessive / surgery*
Portasystemic Shunt, Transjugular Intrahepatic*

Substances

Immunosuppressive Agents